You have 9 free searches left this month | for more free features.

Sprycel®

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

Completed
  • Drug-drug Interaction Study
  • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Nov 20, 2023

Biological Availability Trial in Hyderabad (Dasatinib ASD 100 mg, Dasatinib 140 MG [Sprycel])

Completed
  • Biological Availability
  • Dasatinib ASD 100 mg
  • Dasatinib 140 MG [Sprycel]
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Jun 28, 2022

Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

Completed
  • Leukemia, Myelogenous, Chronic
  • CTTQ Dasatinib tablet
  • Sprycel Dasatinib tablet
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Dec 7, 2022

Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

Not yet recruiting
  • Myeloma Multiple
  • Dasatinib 100 MG
  • Chia, Cundinamarca, Colombia
    CAIMED
Jul 12, 2023

Osteopenia, Osteoporosis Trial in Odense (Dasatinib 100 Mg Oral Tablet, Quercetin 1.250 mg (oral), Nicotinamide Riboside 1g

Recruiting
  • Osteopenia, Osteoporosis
  • Dasatinib 100 Mg Oral Tablet
  • +2 more
  • Odense, Denmark
    Odense University Hospital
Aug 29, 2023

Stem Cell Transplant Trial in Rochester (Quercetin, Standard of Care - Observation Only, Dasatinib)

Recruiting
  • Stem Cell Transplant
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 18, 2022

Aging Trial in Boston (Dasatinib, Quercetin)

Recruiting
  • Aging
  • Boston, Massachusetts
    Hebrew Senior Life
Jun 13, 2022

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Healthy Trial in Rochester (Dasatinib, Quercetin, Fisetin)

Recruiting
  • Healthy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 22, 2022

Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Dasatinib Pill
  • Ketoconazole Pill
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Nov 25, 2022

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Chronic Kidney Disease Trial in Rochester (Group 2: Dasatinib, Group 2: Quercetin)

Enrolling by invitation
  • Chronic Kidney Disease
  • Group 2: Dasatinib
  • Group 2: Quercetin
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 14, 2022

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +53 more
Sep 19, 2022

Frailty, Childhood Cancer Trial in Memphis (Dasatinib plus Quercetin, Fisetin)

Recruiting
  • Frailty
  • Childhood Cancer
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 8, 2022

Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)

Completed
  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  • Valencia, Spain
    Hospital La Fe
Mar 16, 2022

Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)

Terminated
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Chicago, Illinois
  • +1 more
Jun 2, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Chronic Myeloid Leukemia Trial in New Zealand (Dasatinib, Imatinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Auckland, New Zealand
  • +8 more
Mar 10, 2021

Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)

Completed
  • Breast Cancer
  • Bone Metastases
  • Chicago, Illinois
  • +2 more
Feb 2, 2022